A Study to Determine the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Patients With Persistent Anemia Caused by Advanced Cancer
Clinical trial NCT00269984 · COMPLETED
Trial details
- NCT number
- NCT00269984
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.